These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10141 related articles for article (PubMed ID: 1830477)

  • 81. Implementation of an Evidence-Based Practice Change Removing Heparin From Implanted Vascular Access Devices.
    Hoffman M; Fischer-Cartlidge E
    J Infus Nurs; 2022 Sep-Oct 01; 45(5):258-263. PubMed ID: 36112873
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A sensitive fluorometric assay method for mammalian tyrosinase.
    Adachi K; Halprin KM
    Biochem Biophys Res Commun; 1967 Jan; 26(2):242-6. PubMed ID: 6030270
    [No Abstract]   [Full Text] [Related]  

  • 83. Melatonin interactions with cultured murine B16 melanoma cells.
    Helton RA; Harrison WA; Kelley K; Kane MA
    Melanoma Res; 1993 Dec; 3(6):403-13. PubMed ID: 8161880
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Ionic titanocene complexes: a new type of antitumor agent.
    Köpf-Maier P; Neuse E; Klapötke T; Köpf H
    Cancer Chemother Pharmacol; 1989; 24(1):23-7. PubMed ID: 2720888
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [1st Stage I melanoma of the limbs. Prognosis on the basis of the depth of invasion and maximum thickness].
    Bresloy A; Kashinelli N; van der Esh ER; Morabito A
    Vopr Onkol; 1980; 26(11):15-21. PubMed ID: 7456419
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The soft agar clonogenicity and characterization of cells obtained from human solid tumors by mechanical and enzymatic means.
    Slocum HK; Pavelic ZP; Kanter PM; Nowak NJ; Rustum YM
    Cancer Chemother Pharmacol; 1981; 6(3):219-25. PubMed ID: 7032739
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Experimental study of the antitumor anthracycline antibiotic aclarubicin (aclacinomycin A)].
    Egorov LV; Terent'eva TG; Rudneva NA; Egorenko GG; Ivanitskaia LP
    Antibiot Med Biotekhnol; 1985 Dec; 30(12):918-27. PubMed ID: 3866512
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Clonogenic cell survival curves for human melanoma xenografts using agar diffusion chamber and lung colony assays.
    Selby PJ; Thomas JM
    Br J Cancer Suppl; 1980 Apr; 4():150-3. PubMed ID: 6932919
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Paranasal sinus cancer.
    Bridger GP; Mendelsohn MS; Baldwin M; Smee R
    Aust N Z J Surg; 1991 Apr; 61(4):290-4. PubMed ID: 2018438
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Integrins in human cells and tumors.
    Virtanen I; Korhonen M; Kariniemi AL; Gould VE; Laitinen L; Ylänne J
    Cell Differ Dev; 1990 Dec; 32(3):215-27. PubMed ID: 2099238
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Current status and new applications of sentinel lymph node mapping in non-small cell lung cancer].
    Minamiya Y; Ogawa J
    Nihon Geka Gakkai Zasshi; 2009 Mar; 110(2):82-5. PubMed ID: 19348199
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Inhibition of tumor cell adhesion and metastasis].
    Saiki I
    Gan To Kagaku Ryoho; 1993 Feb; 20(3):363-72. PubMed ID: 8439183
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Massive vitreous hemorrhage and senile macular choroidal degeneration.
    Tani PM; Buettner H; Robertson DM
    Am J Ophthalmol; 1980 Oct; 90(4):525-33. PubMed ID: 7424750
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Phase I trial of cisplatin, WR-2721, and the murine monoclonal antibody R24 in patients with metastatic melanoma: clinical and biologic effects.
    Bukowski RM; Murthy SA; Finke J; Caulfield MJ; Tubbs R; Herzog P; Stanley J; Edinger M; Tuason L; McLain D
    J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):273-82. PubMed ID: 8061900
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Interaction of the plasma membranes of the cells of tumors metastasizing to the lungs with the target organ].
    Zolotareva AG; Nikolin VP; Iunker VM; Gruntenko EV; Budker VG; Subbotin VM
    Eksp Onkol; 1989; 11(1):39-43. PubMed ID: 2924708
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Inverse relationship in H-2-associated lysis between NK cells and rIL-2-activated killer cells: evidence from in vitro killing and metastatic experiments.
    Toshitani A; Taniguchi K; Kawano Y; Nomoto K
    Cell Immunol; 1987 Aug; 108(1):188-202. PubMed ID: 3496972
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A new antitumor antibiotic, FR900840. III. Antitumor activity against experimental tumors.
    Nishimura M; Nakada H; Kawamura I; Mizota T; Shimomura K; Nakahara K; Goto T; Yamaguchi I; Okuhara M
    J Antibiot (Tokyo); 1989 Apr; 42(4):553-7. PubMed ID: 2542208
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effects of diflubenzuron on growth of malignant melanoma and skin carcinoma tumors in mice.
    Jenkins VK; Mayer RT; Perry RR
    Invest New Drugs; 1984; 2(1):19-27. PubMed ID: 6432723
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Dislocated intraocular lens simulating a choroidal melanoma.
    Abramson DH; Servodidio CA
    Insight; 1995 Oct; 20(3):18-9. PubMed ID: 7594913
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Phase II trial of recombinant leukocyte A interferon (IFN-alpha 2A) plus 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and the combination cimetidine with BCNU in patients with disseminated malignant melanoma.
    Morton RF; Creagan ET; Schaid DJ; Kardinal CG; McCormack GW; McHale MS; Wiesenfeld M
    Am J Clin Oncol; 1991 Apr; 14(2):152-5. PubMed ID: 2028922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 508.